Highest-materiality recent filing
Hartford Creative Group appoints Kewei Huang as Co-CEO
Board appointed Kewei Huang as Co-Chief Executive Officer on July 22, 2026.
Hartford Creative Group hires IR advisors SBC and Crescendo Communications
Engaged SBC Investor Relations as advisors and Crescendo Communications LLC for investor outreach and strategic communications.
Hartford Creative Group appoints Lili Dai as permanent CFO at $13,300/month
Lili Dai appointed permanent CFO of Hartford Creative Group, effective April 3, 2025; she had been interim CFO since April 2024.
Hartford Creative Group approves 1-for-4 reverse stock split to pursue Nasdaq listing
Board approved 1-for-4 reverse split; effective March 31, 2025 after filing Certificate of Change.
Hartford Creative Group amends CEO contract; $108k salary, term through July 2025
Annualized base salary of $108,000 (payable monthly); term runs through July 31, 2025 with automatic annual renewals.
Hartford Creative Group appoints Jurong Guo and Yiqian Shen to board
Jurong Guo, 61, UBI China Dean and Detong Capital Chairman, appointed independent director effective Oct 7, 2024.
Hartford Creative Group changes name from Hartford Great Health Corp. effective May 11, 2024
Filed amendment with Nevada Secretary of State to change corporate name to Hartford Creative Group, Inc.
Hartford Great Health names Sheng-Yih Chang CEO; Lili Dai interim CFO
CEO Rose Hong Wang resigned effective April 1, 2024; not due to disagreement, no compensation.
Hartford Great Health CEO and CFO resign; new CEO appointed, interim CFO hired
CEO Rose Hong Wang resigns effective April 1, 2024; no disagreement with company.
Hartford Great Health divests two Chinese subsidiaries for total ~$1,900 to stem losses
Transferred 90% of Hartford International Education Technology (Shanghai) to Shanghai Qiaoshang for $900 (RMB ¥5,850).
Hartford Great Health CEO and Chairman Lianyue Song resigns; Rose Hong Wang appointed
On Sept 13, 2021, Lianyue Song resigned as President, CEO, and Chairman of Hartford Great Health Corp.
On July 22, 2026, the Board of Directors appointed Mr. Kewei Huang as Co-Chief Executive Officer of the Company.
On April 3, 2025, the Board of Directors (the “ Board ”) of the Company determined by unanimous written consent to appoint Ms. Dai as the Company’s permanent Chief Financial Officer (“ CFO ”), effective April 3, 2025.
On October 7, 2024, the holders of a majority of the outstanding shares of Common Stock of the Company, by written consent, elected each of Jurong Guo and Yiqian Shen (each, an “ Incoming Director ,” and together, the “ Incoming Directors ”) to the Board, effective immediately.
On October 7, 2024, the holders of a majority of the outstanding shares of Common Stock of the Company, by written consent, elected each of Jurong Guo and Yiqian Shen (each, an “ Incoming Director ,” and together, the “ Incoming Directors ”) to the Board, effective immediately.
the Company appointed Ms. Lili Dai as interim Chief Financial Officer, effective April 01, 2024
Ms. Rose Hong Wang, Chief Executive Officer of Hartford Great Health Corp. (the “Company”), resigned from such position effective April 1, 2024.
Mr. Chang resigned from the position of Chief Financial Officer of the Company, effective the same day.
the Company appointed Mr. Sheng-Yih Chang as Chief Executive Officer.
the Company appointed Ms. Lili Dai as interim Chief Financial Officer, to be effective April 1, 2024, with a term ending March 31, 2025.
Mr. Chang has also tendered his resignation on March 18, 2024 from the position of Chief Financial Officer of the Company, to be effective on April 1, 2024.
Upon Ms. Wang’s departure on April 1, 2024, the Company intends to appoint Mr. Sheng-Yih Chang as Chief Executive Officer.
On March 18, 2024, Ms. Rose Hong Wang, Chief Executive Officer of Hartford Great Health Corp. (the “Company”), tendered her resignation from such position effective April 1, 2024.
Max materiality 0.70 · Median 0.50 · Most common event leadership